IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

venBio Partners L.P.

Q3 2018 Holdings

Filed 2018-11-14 | 3 holdings | $57.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Apellis Pharmaceuticals, IncCOM037530106$31.8K1,790,10255.7%
Menlo Therapeutics Inc.COM586858102$14.4K1,461,55225.2%
Verona Pharma PLC(VRNA)SPONSORED ADS925050106$10.9K875,00019.1%